Published in
Taylor and Francis Group, Expert Review of Pharmacoeconomics and Outcomes Research, 3(14), p. 425-435, 2014
DOI: 10.1586/14737167.2014.908713
Links
Tools
Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 